Breast Cancer Trial, Recruiting NCT07120087 Sponsor: UNICANCER Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07120087
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who identify as female, whether born female or not
  • People aged between 40 and 74 years old (inclusive)
  • People who have previously joined, or are currently taking part in, a separate study called MyPeBS, and who met all of that study's joining requirements
  • People who are able to express that they do not object to taking part in this trial
  • People who were assessed in the MyPeBS study as having a high or very high chance of developing invasive breast cancer within the next 5 years (specifically, a risk level of 1.67% or above)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who were diagnosed with breast cancer at any point during their time in the MyPeBS study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
UNICANCER
Registry
ClinicalTrials.gov
Start date
19 February 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇫🇷 France 🇮🇹 Italy

Primary endpoints

Acceptance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov